Brandon Essink, MD, CPI, is Lead Author of Article Providing Update on Zika Virus Vaccine Development

Brandon Essink, MD, CPI, was the lead author of the article, “The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials”. Dr. Essink oversaw two phase 1 studies that evaluated the safety and immunogenicity of two mRNA-based Zika virus vaccines (Moderna’s mRNA-1325 and mRNA-1893) in adults. Read the article on The Lancet:

Posted in

Quality. Continuity. Velocity.